249 related articles for article (PubMed ID: 31158732)
21. Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma.
Guo W; Huang J; Wang N; Tan HY; Cheung F; Chen F; Feng Y
Front Pharmacol; 2019; 10():1185. PubMed ID: 31649545
[TBL] [Abstract][Full Text] [Related]
22. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
23. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
24. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology.
Yu Q; Chen Z; Liu M; Meng Y; Li X; Li B; Du J
J Ethnopharmacol; 2022 Oct; 297():115531. PubMed ID: 35840058
[TBL] [Abstract][Full Text] [Related]
25. In silico analysis and experimental validation to exhibit anti-nasopharyngeal carcinoma effects of plumbagin, an anti-cancer compound.
Liang X; Pan Q; Liao Y; Nie L; Yang L; Liu F; Su M
J Sci Food Agric; 2022 Sep; 102(12):5460-5467. PubMed ID: 35355274
[TBL] [Abstract][Full Text] [Related]
26. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
27. Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma.
Liu P; Han B; Zhang Y; Wang X
Comput Intell Neurosci; 2022; 2022():7102500. PubMed ID: 35720901
[TBL] [Abstract][Full Text] [Related]
28. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
29. Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators.
Zhang XQ; Yang CY; Rao XF; Xiong JP
Eur J Gynaecol Oncol; 2016; 37(1):30-5. PubMed ID: 27048106
[TBL] [Abstract][Full Text] [Related]
30. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
[TBL] [Abstract][Full Text] [Related]
31. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
[TBL] [Abstract][Full Text] [Related]
32. Diosgenin induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.
Li Y; Wang X; Cheng S; Du J; Deng Z; Zhang Y; Liu Q; Gao J; Cheng B; Ling C
Oncol Rep; 2015 Feb; 33(2):693-8. PubMed ID: 25434486
[TBL] [Abstract][Full Text] [Related]
33. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
34. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
37. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
38. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
40. Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma.
Chen Z; Lin T; Liao X; Li Z; Lin R; Qi X; Chen G; Sun L; Lin L
Chin Med; 2021 Jan; 16(1):13. PubMed ID: 33478536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]